Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

BiomX (PHGE) News Today

BiomX logo
$0.55 +0.00 (+0.60%)
As of 04:10 PM Eastern
Compare

PHGE Latest News

HC Wainwright Issues Optimistic Estimate for BiomX Earnings
August 23 at 2:36 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30292137
HC Wainwright Reaffirms Buy Rating for BiomX (NYSEAMERICAN:PHGE)
August 21, 2025  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30289755
BiomX announces U.S. FDA placed clinical hold on Phase 2b trial of BX004
August 19, 2025  |  msn.comhttps://www.msn.com/en-us/health/other/biomx-announces-us-fda-placed-clinical-hold-on-phase-2b-trial-of-bx004/ar-AA1KOym1
BiomX Faces FDA Hold on Phase 2b Study
August 19, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/biomx-faces-fda-hold-on-phase-2b-study?utm_source=marketbeat.com&utm_medium=referral
BiomX Inc: BiomX Provides Update on BX004 Phase 2b Trial for the Treatment of Patients with Cystic Fibrosis
August 19, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-08/66216093-biomx-inc-biomx-provides-update-on-bx004-phase-2b-trial-for-the-treatment-of-patients-with-cystic-fibrosis-399.htm
BiomX Inc. (AMEX:PHGE) Q2 2025 Earnings Call Transcript
August 14, 2025  |  msn.comhttps://www.msn.com/en-us/money/markets/biomx-inc-amexphge-q2-2025-earnings-call-transcript/ar-AA1Kw6MB
BiomX Inc. Reports Q2 2025 Progress and Financials
August 14, 2025  |  msn.comhttps://www.msn.com/en-us/money/general/biomx-inc-reports-q2-2025-progress-and-financials/ar-AA1Kv0h8
BiomX Publishes Promising Phase 1b/2a Trial Results
July 8, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/biomx-publishes-promising-phase-1b-2a-trial-results?utm_source=marketbeat.com&utm_medium=referral
BiomX Highlights Progress in Phage Therapy Advancements
June 9, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/biomx-highlights-progress-in-phage-therapy-advancements?utm_source=marketbeat.com&utm_medium=referral
BiomX Inc (PHGE) Q1 2025 Earnings Call Highlights: Strategic Advances and Financial Resilience
May 16, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/biomx-inc-phge-q1-2025-071323334.html
BiomX Stock Short Interest Report | AMEX:PHGE | Benzinga
May 11, 2025  |  benzinga.comhttps://www.benzinga.com/quote/PHGE/short-interest
BiomX Inc. to Host Conference Call for First Quarter 2025 Financial Results and Business Updates
May 9, 2025  |  nasdaq.comhttps://www.nasdaq.com/articles/biomx-inc-host-conference-call-first-quarter-2025-financial-results-and-business-updates
BiomX Inc.
April 21, 2025  |  barrons.comhttps://www.barrons.com/market-data/stocks/phge/company-people
BiomX reports ‘positive’ results from 2 trial evaluating BX211
April 1, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biomx-reports-positive-results-from-2-trial-evaluating-bx211-1034532938
BiomX Announces a Series of Financings for Aggregate Gross Proceeds of $12 Million
February 26, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/biomx-announces-series-financings-aggregate-130000810.html
BiomX Inc. Receives Notice of Compliance with NYSE American Continued Listing Standards
December 16, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biomx-inc-receives-notice-of-compliance-with-nyse-american-continued-listing-standards-1034140102
BiomX Inc (PHGE) Q3 2024 Earnings Call Highlights: Strong Net Income Amid Rising Expenses
November 16, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/biomx-inc-phge-q3-2024-070753311.html
BiomX Inc: Promising Clinical Advancements and Strong Financial Position Justify Buy Rating
November 15, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biomx-inc-promising-clinical-advancements-and-strong-financial-position-justify-buy-rating-1034020246
BiomX Inc. Reports Q3 2024 Financial Turnaround
November 15, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biomx-inc-reports-q3-2024-financial-turnaround-1034022414
BiomX announces mandatory unit separation
October 16, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/biomx-announces-mandatory-unit-separation-110516471.html
BiomX Inc (PHGE) Q2 2024 Earnings Call Highlights: Strong Financial Turnaround and Promising ...
October 9, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/biomx-inc-phge-q2-2024-222918108.html
BiomX (AMEX:PHGE) Stock Quotes, Forecast and News Summary
October 4, 2024  |  benzinga.comhttps://www.benzinga.com/quote/PHGE
BiomX to Present Positive Phase 1b/2a Clinical Trial Data for BX004 at the European Respiratory Society (ERS) Congress 2024
September 3, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/biomx-present-positive-phase-1b-120000962.html
BiomX Inc. (NYSEAMERICAN:PHGE) Short Interest Update
August 27, 2024  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/nyseamerican-phge-options-data-report-2024-08-27/
Upcoming Stock Splits This Week (August 26 to August 30) – Stay Invested
August 26, 2024  |  msn.comhttps://www.msn.com/en-us/money/companies/upcoming-stock-splits-this-week-august-26-to-august-30-stay-invested/ar-AA1psHYS
Earnings call: BiomX reports Q2 2024 financials, clinical updates
August 18, 2024  |  uk.investing.comhttps://uk.investing.com/news/stock-market-news/earnings-call-biomx-reports-q2-2024-financials-clinical-updates-93CH-3655455
Buy Rating for BiomX: Solid Financials and Promising Clinical Pipeline Signal Strong Future Performance
August 16, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/buy-rating-for-biomx-solid-financials-and-promising-clinical-pipeline-signal-strong-future-performance-1033701278
BiomX Buy Rating Affirmed by Analyst Michael Higgins on Strong Clinical Progress and Strategic Acquisitions
August 16, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biomx-buy-rating-affirmed-by-analyst-michael-higgins-on-strong-clinical-progress-and-strategic-acquisitions-1033700501
BiomX receives NYSE American compliance extension
July 31, 2024  |  investing.comhttps://www.investing.com/news/company-news/biomx-receives-nyse-american-compliance-extension-93CH-3542158
Laidlaw & Co. Initiates Coverage of BiomX (PHGE) with Buy Recommendation
May 29, 2024  |  msn.comhttps://www.msn.com/en-us/money/markets/laidlaw-co-initiates-coverage-of-biomx-phge-with-buy-recommendation/ar-BB1nf9lJ
BiomX Buy Rating Affirmed on Clinical Progress and Strategic Acquisition
May 22, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biomx-buy-rating-affirmed-on-clinical-progress-and-strategic-acquisition-1033411858
BiomX Inc. (AMEX:PHGE) Q1 2024 Earnings Call Transcript
May 22, 2024  |  msn.comhttps://www.msn.com/en-us/money/markets/biomx-inc-amexphge-q1-2024-earnings-call-transcript/ar-BB1mQAvV
BiomX’s Strategic Progress and Positive Trials Fuel Buy Rating
May 21, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biomx-s-strategic-progress-and-positive-trials-fuel-buy-rating-1033408633
BiomX Inc. (PHGE) Q4 2023 Earnings Call Transcript
April 5, 2024  |  seekingalpha.comhttps://seekingalpha.com/article/4681989-biomx-inc-phge-q4-2023-earnings-call-transcript
BiomX Inc. (AMEX:PHGE) Q4 2023 Earnings Call Transcript
April 4, 2024  |  msn.comhttps://www.msn.com/en-us/money/markets/biomx-inc-amexphge-q4-2023-earnings-call-transcript/ar-BB1l4TdS
BiomX’s Robust Financial Health and Promising Clinical Advancements Bolster Buy Rating
April 4, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biomx-s-robust-financial-health-and-promising-clinical-advancements-bolster-buy-rating-1033220140
Azitra stock slides on pricing stock offering to raise $5 million
February 14, 2024  |  msn.comhttps://www.msn.com/en-us/money/markets/azitra-stock-slides-on-pricing-stock-offering-to-raise-5-million/ar-BB1ifOPT
BiomX to Host Virtual Key Opinion Leader (KOL) Event to Review the Positive Results from Part 2 of Phase 1b/2a Trial of BX004 in Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections on December 4, 2023
November 30, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/biomx-host-virtual-key-opinion-211500021.html?.tsrc=rss
Why Is Bacterial Infection-Focused BiomX Stock Trading Lower Today?
November 29, 2023  |  benzinga.comhttps://www.benzinga.com/general/biotech/23/11/36004212/why-is-bacterial-infection-focused-biomx-stock-trading-lower-today
BiomX mulls pivotal trial for antibacterial after Phase 1/2 data in cystic fibrosis
November 29, 2023  |  msn.comhttps://www.msn.com/en-us/money/markets/biomx-mulls-pivotal-trial-for-antibacterial-after-phase-12-data-in-cystic-fibrosis/ar-AA1kIItu
BiomX Announces Positive Results From Phase 1b/2a Study Of BX004 In Chronic Pulmonary Infections
November 29, 2023  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/biomx-announces-positive-results-from-phase-1b-2a-study-of-bx004-in-chronic-pulmonary-infections-1032858102
BiomX: BX004 Phage Cocktail Part 2, Phase 1b/2a Clinical Results In Cystic Fibrosis Expected Any Day
November 23, 2023  |  seekingalpha.comhttps://seekingalpha.com/article/4653887-biomx-bx004-phage-cocktail-part-2-phase-1b2a-clinical-results-cystic-fibrosis-expected-soon
Promising Clinical Trials and Financial Stability Bolster BiomX’s Buy Rating: An Analysis by Michael Higgins
November 16, 2023  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/promising-clinical-trials-and-financial-stability-bolster-biomx-s-buy-rating-an-analysis-by-michael-higgins-1032824867
Analysts Offer Insights on Healthcare Companies: BiomX (PHGE), Quoin Pharmaceuticals (QNRX) and Precigen (PGEN)
November 15, 2023  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/analysts-offer-insights-on-healthcare-companies-biomx-phge-quoin-pharmaceuticals-qnrx-and-precigen-pgen-1032819958
BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the 37th Annual North American Cystic Fibrosis Conference
October 27, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/biomx-present-data-ongoing-phase-120000510.html?.tsrc=rss
BiomX Announces the Appointment of Edward L. Williams to its Board of Directors
October 18, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/biomx-announces-appointment-edward-l-120000991.html?.tsrc=rss
BiomX Announces Completion of Patient Dosing in Part 2 of the Phase 1b/2a Study Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis
October 4, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/biomx-announces-completion-patient-dosing-103400631.html?.tsrc=rss
BiomX to Present Data from Ongoing Phase 1b/2a Study Evaluating BX004 for the Treatment of Chronic Pseudomonas aeruginosa Pulmonary Infections in Patients with Cystic Fibrosis at the European Respiratory Society (ERS) International Congress 2023
September 7, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/biomx-present-data-ongoing-phase-130000079.html?.tsrc=rss
BiomX to Present at H.C. Wainwright 25th Annual Global Investment Conference
September 6, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/biomx-present-h-c-wainwright-200500037.html?.tsrc=rss
BiomX Reports Second Quarter 2023 Financial Results and Provides Business Update
August 9, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/biomx-reports-second-quarter-2023-103000063.html?.tsrc=rss
Get BiomX News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHGE and its competitors with MarketBeat's FREE daily newsletter.

PHGE Media Mentions By Week

PHGE Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PHGE
News Sentiment
▼
0.41

0.71
▲
Average
Medical
News Sentiment

PHGE News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PHGE Articles
This Week
▼
9

0
▲
PHGE Articles
Average Week

Get BiomX News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHGE and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies
Headlines Tools

This page (NYSEAMERICAN:PHGE) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsoredtc pixel
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsoredtc pixel
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsoredtc pixel